Editorial overview: Musculoskeletal: Are we on the road to personalised medicine in musculoskeletal diseases?
作者信息
Gartland Alison, Hocking Lynne J
机构信息
The Mellanby Centre for Bone Research, Department of Human Metabolism, The University of Sheffield, Sheffield, UK.
Musculoskeletal Research Programme, Division of Applied Medicine, University of Aberdeen, Foresterhill, Aberdeen, UK.
出版信息
Curr Opin Pharmacol. 2014 Jun;16:vii-ix. doi: 10.1016/j.coph.2014.06.001. Epub 2014 Jun 6.
PMID:24909125
Abstract
摘要
相似文献
1
Editorial overview: Musculoskeletal: Are we on the road to personalised medicine in musculoskeletal diseases?社论概述：肌肉骨骼系统：我们正朝着肌肉骨骼疾病的个性化医疗迈进吗？
Curr Opin Pharmacol. 2014 Jun;16:vii-ix. doi: 10.1016/j.coph.2014.06.001. Epub 2014 Jun 6.
2
Turning genetic discoveries into new treatments: the Wnt/LRP-5 system as a source of new drug targets for skeletal diseases.将基因发现转化为新疗法：Wnt/LRP-5系统作为骨骼疾病新药物靶点的来源
J Musculoskelet Neuronal Interact. 2008 Oct-Dec;8(4):296-7.
3
Stratified medicine approaches for the treatment of musculoskeletal disorders.用于治疗肌肉骨骼疾病的分层医学方法。
Curr Opin Pharmacol. 2014 Jun;16:127-32. doi: 10.1016/j.coph.2014.05.003. Epub 2014 Jun 2.
4
Targeting P2 receptors--current progress in treating musculoskeletal diseases.靶向P2受体——治疗肌肉骨骼疾病的当前进展
Curr Opin Pharmacol. 2014 Jun;16:122-6. doi: 10.1016/j.coph.2014.05.004. Epub 2014 May 28.
5
[Musculoskeletal Tumor].[肌肉骨骼肿瘤]
Gan To Kagaku Ryoho. 2017 Mar;44(3):211.
6
Editorial overview: Musculoskeletal 2020 - adipokines.编辑概述：2020年肌肉骨骼领域——脂肪因子
Curr Opin Pharmacol. 2020 Jun;52:iii-v. doi: 10.1016/j.coph.2020.06.002. Epub 2020 Jul 8.
7
Editorial overview: Musculoskeletal: Where are we with treating musculoskeletal disorders?社论综述：肌肉骨骼系统：我们在治疗肌肉骨骼疾病方面处于什么位置？
Curr Opin Pharmacol. 2016 Jun;28:iv-vi. doi: 10.1016/j.coph.2016.03.004. Epub 2016 Apr 8.
8
Global gene expression distribution in non-cancerous complex diseases.非癌性复杂疾病中的全局基因表达分布
Mol Biosyst. 2014 Apr;10(4):728-31. doi: 10.1039/c3mb70524b. Epub 2014 Jan 31.
9
The therapeutic potential of blocking the activin signalling pathway.阻断激活素信号通路的治疗潜力。
Cytokine Growth Factor Rev. 2013 Oct;24(5):477-84. doi: 10.1016/j.cytogfr.2013.04.006. Epub 2013 Jun 18.
10
Genomics in the assessment of a multi-component, multi-target medication in soft tissue disorders.
Curr Med Res Opin. 2013;29 Suppl 2:11-4. doi: 10.1185/03007995.2013.779879.
Zotero 插件